CureVac NV Capital Reinvestment Ratio

Latest as of September 2025: 0.01x

CureVac NV capital reinvestment ratio. CureVac NV (5CV) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow (€29.86 Million) in capital expenditures (€322.00K). Check CureVac NV total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

€29.86 Million
EUR

Capital Expenditures

€322.00K
EUR

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of CureVac NV (2020–2024)

Capital reinvestment ratio of CureVac NV from 2020 to 2024. This chart tracks CureVac NV's Capital Reinvestment Ratio across 2 annual periods. Also explore net asset growth rate of CureVac NV to track the company's year-over-year net asset growth rate.

CureVac NV Capital Reinvestment Ratio by Year (2020–2024)

CureVac NV capital reinvestment ratio by year from 2020 to 2024. For the full cash flow conversion analysis, see CureVac NV operating cash flow efficiency.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2024 0.18x €101.85 Million €18.44 Million ▲ +160.4%
2020 0.07x €522.40 Million €36.33 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow